Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in OCGN — Ocugen, Inc.

CIK 1390777 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,237,516
+$1,081,644 QoQ
Shares Held
808,835
+839.2% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. OCGN ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in OCGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,237,516 808,835
2026-03-31 $155,872 86,118
2025-12-31 $50,023 37,055
2025-09-30 $60,399 37,055
2025-06-30 $24,171 24,920
2025-03-31 $414,764 587,487
2024-12-31 $438,885 545,201
2024-09-30 $540,992 545,357
2024-06-30 $1,165,318 751,819
2024-03-31 $43,103 26,283
2023-12-31 $50,457 87,752
2023-09-30 $35,100 87,752
2023-06-30 $73,527 135,410
2023-03-31 $841,537 986,562
2022-12-31 $1,258,086 967,759
2022-09-30 $1,708,715 959,953
2022-06-30 $2,035,867 896,858
2022-03-31 $2,490,027 754,554
2021-12-31 $3,571,075 784,852
2021-09-30 $5,482,654 763,601
2021-06-30 $5,584,230 695,421
2021-03-31 $598,973 88,214
2020-12-31 $197,306 107,818